CD44 also facilitates tumor angiogenesis, immunosuppression, and metabolic reprogramming through interactions with STAT3, thereby supporting the pro-tumorigenic tumor microenvironment (Wielenga et al., 1993; Ponta et al., 2003; Li et al., 2014). The gene discussed is STAT3; the disease is neoplasm.